The IFN-γ gene polymorphism may further affect the development of HCC and the response to cancer drugs by increasing the risk of hepatitis virus-related diseases, although we did not observe a significant association between the (+874T/A) polymorphism and HCC risk in this study, which is worthy of further investigation in the future. The gene discussed is IFNG; the disease is hepatocellular carcinoma.